Fentanyl as an Adjuvant to Peribulbar Block in Buckle or Squint Surgeries
NCT ID: NCT05539911
Last Updated: 2022-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
50 participants
INTERVENTIONAL
2022-09-01
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our study will assess its efficacy in abolishing pain during muscle traction which is usually a complain for many patients a reason to use systemic opioid intra operatively or even general anesthesia
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrobulbar Block Versus Ketamine Infusion for Post-enucleation Analgesia
NCT03507426
Nalbuphine, Fentanyl and no Additive to Local Anaesthetic Mixture
NCT03824665
Comparative Study Between Two Adjuvant Drugs to Bupivacaine for Post-operative Epidural Analgesia in Abdominal Surgeries
NCT05323214
Comparison Between Fentanyl and Dexmedetomidine As Adjuvant to Bupivacaine in Combined IPACK and Adductor Canal Block for Postoperative Analgesia After Knee Surgeries
NCT06759116
Comparing Efficacy of Different Drugs Combinations for Serratus Anterior Block for Thoracotomy
NCT05565235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Nasal oxygen cannula connected; 10 ml of local anesthetic mixture is injected depending on the group the patient is allocated.
Increments of intravenous intravenous fentanyl and midazolam will be given if patient experienced unbearable pain.
All patient received peribulbar block by an experienced anesthesiologist, both patient and anesthesiologist were blinded to the drug mixture used.
Each patient received 10 ml of the anesthetic mixture according to his/ her group.
The patient was asked to fix his eyes looking straight forward toward the ceiling while lying in a supine position. A 10 ml syringe with a 25G needle was used for the local anesthetic injection. After negative aspiration, the first 5 ml were slowly injected at the junction of the lateral one third and medial two thirds of the inferior orbital margin with the bevel directed towards the equator of the eye ball parallel to the orbital floor and the other 5 ml were given between the caruncle and the medial canthus. Intermittent gentle massage was applied for 10 minutes. After satisfactory sensory and motor block, oxygen 3 L/min was delivered through a nasal cannula to the patient. Surgery was then allowed to proceed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group f
patient received 50 mic fentanyl as an adjuvant to the local anesthetic mixture applied during peribulbar block in the operative eye
Fentanyl
50 mic fentanyl added as an adjuvant
group C
received the traditional mixture used
Fentanyl
50 mic fentanyl added as an adjuvant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fentanyl
50 mic fentanyl added as an adjuvant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 to 70
* Patients undergoing squint or buckle surgeries
Exclusion Criteria
* Refusal of the patient for peribulbar block
* Redo squint surgeries or previous buckle insertion
* High axial length if documented
* mentally retarded patients and
* failure of proper communication as in deafness,
* coagulation abnormalities (INR\>1.4),
* infection at the injection site
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Research Institute of Ophthalmology, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abeer S Salem, MD
Role: PRINCIPAL_INVESTIGATOR
Research Institute of Ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Institute of Ophthalmology
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Abeer Samir Salem, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00abeer00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.